Breast Lesion Localization Market worth $0.4 billion by 2028, with a CAGR of 6.9%
The report "Breast Lesion Localization Market By Type (Wire, Radioisotope (ROLL, RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy, Lumpectomy), End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) - Global Forecast to 2028", is expected to reach USD 0.4 billion by 2028 from USD 0.3 billion in 2023, will grow at a CAGR of 6.9% during the forecast period.
Browse 249 market data Tables and 59 Figures spread through 281 Pages and in-depth TOC on "Breast Lesion Localization Market, By Type (Wire, Radioisotope (ROLL, RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy, Lumpectomy), End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/breast-lesion-localization-methods-market-35768623.html
Factors contributing to the market growth are improvements in the reimbursement policies, high incidence rate of breast cancer, and increasing breast cancer screening programs globally. In addition, the increasing number of breast cancer surgeries and rising awareness on the early detection of breast cancer is supporting the growth of this market.
Wire localization accounted for the largest share of the breast lesion localization market.
Based on type, the breast lesion localization market is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization types. In 2022, the wire localization segment commanded the largest share of the breast lesion localization market due to widespread availability, moderate pricing, the simple storing requirements of wires, multiple ways of usage that can be used with a wide variety of image guidance techniques, the appropriate localization of abnormal tissues, minimum removal of normal tissues, minimum scarring, and the availability of reimbursement.
The hospitals & clinics segment accounted for the largest share of the breast lesion localization market.
Based on end user, the breast lesion localization market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic imaging centers, and other end users. Hospitals and clinics are the major end users of breast lesion localization market. The large share of this end-user segment can be attributed to the growing healthcare sector in emerging economies, the increasing out-of-pocket healthcare expenditure across the world, and the rising number of breast biopsy procedures.
North America segment accounted for the largest share of the breast lesion localization market.
The global breast lesion localization market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America segment accounted for the largest share of the breast lesion localization market, followed by Europe and Asia Pacific. Factors such as, increasing prevalence of breast cancer, growing healthcare expenditure, and the increasing number of awareness programs for the early detection of breast cancer are boosting the market growth in North America.
Some of the major market players in the breast lesion localization market include Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Breast Lesion Localization Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
